Latest disorders Stories
SAN DIEGO, Feb. 3, 2011 /PRNewswire/ -- Otonomy, Inc., a developer of innovative therapeutics for disorders of the ear, today announced the appointments of G. Michael Wall, Ph.D., as the company's vice president of product development and Cindy Berejikian as the company's vice president of program management. The appointments of Dr. Wall and Mrs. Berejikian, each of whom possesses extensive global pharmaceutical product development and commercialization expertise, further advance Otonomy's...
KING OF PRUSSIA, Pa., Jan. 20, 2011 /PRNewswire/ -- CSL Behring, a global leader in the plasma protein biotherapies industry and a subsidiary of CSL Limited (ASX:CSL), has awarded advocacy grants totaling almost $100,000 to six patient organizations through the Local Empowerment for Advocacy Development (LEAD) program. LEAD grants support the grassroots advocacy efforts of organizations committed to helping people who use plasma-derived or recombinant therapies to manage rare and serious...
Sleep diseasesIn one of the largest studies of its kind Danish sleep researchers from the University of Copenhagen and the Danish Institute for Health Services Research have examined the socio-economic consequences of the sleep disorders snoring, sleep apnoea, and obesity-related respiratory difficulties (obesity hypoventilation syndrome (OHS)). These disorders are a serious health and social-economic burden on the individual and on society as a whole."Snoring, sleep apnoea, and...
Scientists in Connecticut have carried out one of the first psychological studies into eating disorders in Native American (NA) populations. The research, published in The International Journal of Eating Disorders, provides new insights into the extent to which Native American populations experience eating disorders, revealing that women are more likely to report behavioral symptoms then men, while challenging views that NA men and ethnically white men will experience different psychological...
University of Adelaide researchers are a step closer to unraveling the mysteries of human sexual development, following genetic studies that show male mice can be created without a Y chromosome "“ through the activation of an ancient brain gene.Males usually have one Y chromosome and one X chromosome, while females have two X chromosomes. A single gene on the Y, called SRY, triggers testes development in the early embryo, and once these begin to form, the rest of the embryo also becomes...
LOUISVILLE, Colo., Dec. 17, 2010 /PRNewswire/ -- Pier Pharmaceuticals Inc.(formerly known as Steady Sleep Rx Co.), a clinical stage biopharmaceutical company focused on the treatment of sleep related breathing disorders (SRBDs), announced today the appointment of Peter W. Letendre, Pharm.D. as its CEO & President and his election to the Board of Directors. As CEO and President, Dr. Letendre will be responsible for spearheading the clinical, regulatory, IP and strategic direction of the...
A new twin-study has found that their co-occurrence may be linked to slow processing speedAttention Deficit Hyperactivity Disorder (ADHD) and developmental reading disability (RD) are complex childhood disorders that frequently occur together; if a child is experiencing trouble with reading, symptoms of ADHD are often also present. However, the reason for this correlation remains unknown. A new study reported in the latest special issue of Cortex...
Oklahoma's need for hospitals providing specialty care is certainly immense; Brookhaven Hospital, a comprehensive health center for the treatment of behavioral health and neurologic disorders, has expanded to meet these needs. The facility, located in the scenic outskirts of east Tulsa, has added 24 new inpatient beds. The expansion has allowed for a total of 28 beds for individuals with traumatic brain injury and 16 additional beds for patients with behavioral health needs. All told, the...
SEATTLE, Nov. 23, 2010 /PRNewswire-FirstCall/ -- Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has completed the acquisition of a GPCR assay technology, comprised of patents and other intellectual property rights, from Patobios Limited (Patobios). During the preceding exclusive option period with Patobios, Omeros...
DENVER, Nov. 22, 2010 /PRNewswire/ -- On November 20 at the American Society of Nephrology 43rd Annual Meeting, Columbia University Assistant Professor of Clinical Medicine Andrew Bomback, MD, presented results from a patient case series assessing the potential therapeutic value of H.P. Acthar® Gel (repository corticotropin injection) as a treatment for patients with nephrotic syndrome, a kidney disorder characterized by excessive loss of urinary protein. Initial data presented at the...
